Leonard Schleifer | President, Chief Executive Officer |
George Yancopoulos | President, Chief Scientific Officer |
Marion McCourt | Executive Vice President, Head of Commercial |
Robert Landry | Executive Vice President, Chief Financial Officer |
Ryan Crowe | Vice President, Investor Relations |
Chris Raymond | Piper Sandler |
Cory Kasimov | JP Morgan |
Evan Siegerman | BMO Capital Markets |
Salveen Richter | Goldman Sachs |
Brian Abrahams | RBC Capital Markets |
Carter Gould | Barclays Capital |
Luke Hermann | Baird |
Brittany Woods | Cowen & Co. |
Dane Leone | Raymond James |
Charlie Yang | Morgan Stanley |
Mohit Bansal | Wells Fargo |
Welcome to the Regeneron Pharmaceuticals first quarter 2022 earnings conference call. My name is Gigi and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session. Please note that this conference is being recorded.